Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism.
HUVEC
M2 macrophages
OXPHOS
RiPPs
TAM-like macrophages
flow cytometry
migration
mitochondria
phagocytosis
qPCR
scratch assay
thioviridamide-like compounds
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
19 May 2020
19 May 2020
Historique:
received:
09
04
2020
revised:
12
05
2020
accepted:
13
05
2020
entrez:
23
5
2020
pubmed:
23
5
2020
medline:
23
5
2020
Statut:
epublish
Résumé
Natural products represent powerful tools searching for novel anticancer drugs. Thioholgamide A (thioA) is a ribosomally synthesized and post-translationally modified peptide, which has been identified as a product of
Identifiants
pubmed: 32438733
pii: cancers12051288
doi: 10.3390/cancers12051288
pmc: PMC7281193
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : KI702
Organisme : Saarland Landesforschungsförderung
ID : LFFP 17/08
Références
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
Clin Cancer Res. 2018 Jun 1;24(11):2482-2490
pubmed: 29420223
Microb Cell Fact. 2020 Jan 9;19(1):5
pubmed: 31918711
Cell Death Differ. 2016 Sep 1;23(9):1542-54
pubmed: 27206315
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Drugs. 2007;67(15):2257-76
pubmed: 17927287
J Antibiot (Tokyo). 2006 Jan;59(1):1-5
pubmed: 16568712
Genome Biol. 2017 Dec 20;18(1):234
pubmed: 29262845
J Cell Physiol. 2019 Nov;234(11):20298-20309
pubmed: 30972784
ACS Chem Biol. 2017 Nov 17;12(11):2837-2841
pubmed: 28981254
Gastroenterology. 2019 Dec;157(6):1615-1629.e17
pubmed: 31446059
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Immunol Invest. 2017 May;46(4):361-374
pubmed: 28375674
Cell Immunol. 2018 Feb;324:1-7
pubmed: 29129293
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Anal Biochem. 2013 Feb 15;433(2):105-11
pubmed: 23085117
ACS Chem Biol. 2019 Aug 16;14(8):1819-1828
pubmed: 31365229
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
Nat Rev Drug Discov. 2018 Dec;17(12):887-904
pubmed: 30361552
Front Immunol. 2019 Oct 17;10:2368
pubmed: 31681276
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
Rheumatology (Oxford). 2016 Dec;55(12):2260-2270
pubmed: 27632996
Dis Model Mech. 2014 Jul;7(7):745-54
pubmed: 24973744
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
PLoS One. 2015 Oct 06;10(10):e0139598
pubmed: 26440936
Cancer Cell. 2013 Feb 11;23(2):249-62
pubmed: 23410977
Cell. 2019 Jun 13;177(7):1903-1914.e14
pubmed: 31031007
Adv Exp Med Biol. 2016;930:205-39
pubmed: 27558823
Trends Immunol. 2015 Apr;36(4):229-39
pubmed: 25770924
Cells. 2019 Nov 08;8(11):
pubmed: 31717378
Allergy. 2011 Mar;66(3):396-403
pubmed: 20973804
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
J Hepatol. 2015 Dec;63(6):1323-33
pubmed: 26220749
Front Microbiol. 2018 Aug 07;9:1801
pubmed: 30135682
Int J Mol Sci. 2019 Feb 15;20(4):
pubmed: 30781344
Sci Rep. 2015 Jun 22;5:11453
pubmed: 26095213
J Biol Chem. 2017 Dec 22;292(51):21102-21116
pubmed: 29074620
Trends Immunol. 2017 Jun;38(6):395-406
pubmed: 28396078
Sci Rep. 2019 Sep 26;9(1):13923
pubmed: 31558752
PLoS One. 2012;7(8):e42656
pubmed: 22880072
Methods Enzymol. 2014;547:309-54
pubmed: 25416364
Blood. 2006 Jun 15;107(12):4930-7
pubmed: 16497970
Front Oncol. 2017 Aug 28;7:186
pubmed: 28894696
Int J Biol Sci. 2019 Mar 10;15(5):984-998
pubmed: 31182919
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
Cell Metab. 2019 Jul 2;30(1):36-50
pubmed: 31269428
Eur Respir J. 2007 Oct;30(4):627-32
pubmed: 17537769
Curr Opin Pharmacol. 2017 Aug;35:12-19
pubmed: 28538141
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Biol Chem. 1998 Apr 17;273(16):9357-60
pubmed: 9545256
Nat Rev Immunol. 2019 Jun;19(6):369-382
pubmed: 30718830
Blood. 2010 Jan 14;115(2):353-62
pubmed: 19880493